Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Boone Capital Management Llc
Form 13F · Q2 2026

Boone Capital Management Llc

CIK 1882053Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$428M
Reported book value
16
Positions
12
Quarters on record
Top 50
Positions

Boone Capital Management Llc — holdings

Top 16 positions of 16, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1TFX Teleflex Incorporated387,388+39.0%$49M11.5%
2MIRM Mirum Pharmaceuticals Inc415,641−1.3%$49M11.4%
3CI The Cigna Group159,290+15.8%$44M10.3%
4IONS Ionis Pharmaceuticals Inc519,977+3.9%$41M9.6%
5UNH Unitedhealth Group Inc88,687+11.9%$37M8.6%
6BMRN Biomarin Pharmaceutical Inc583,219+6.5%$33M7.8%
7GUARDIAN PHARMACY SVCS INC Guardian Pharmacy Svcs Inc711,939+12.8%$30M7.0%
8VSTS Vestis Corporation1.9M—$28M6.5%
9BBIO Bridgebio Pharma Inc339,720+48.5%$25M5.9%
10PNTG Pennant Group Inc515,818—$19M4.5%
11GLUE Monte Rosa Therapeutics Inc615,287—$15M3.5%
12KOD Kodiak Sciences Inc378,010+34.4%$15M3.4%
13TNGX Tango Therapeutics Inc455,605—$14M3.3%
14KYMR Kymera Therapeutics Inc113,173—$13M3.0%
15CGEM Cullinan Therapeutics Inc704,442—$13M3.0%
16ANL Adlai Nortye Ltd258,390—$3M0.7%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.